Leader in microbiology innovation
Please log in for more information
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!
Subscribe to The Pathologist Newsletters
QuantaMatrix was founded in 2010 as an ivd company by Dr. Sunghoon Kwon, professor at Seoul National University in Korea. Our mission is to treat sepsis & antibiotics misuse by providing optimal antimicrobial prescription with our dRASTTM platform.
Minimizing time to optimal treatment is directly linked to patient survival., dRASTTM decreases the time to result by 30-50 hours. By reducing exposure to broad-spectrum treatment with dRASTTM, more optimal treatment against bacterial infection is available sooner and prevent antimicrobial resistance. Shortened treatment time helps reducing global healthcare cost with shorter length of stay in hospital.
Our goal is to continue to innovate in microbiology, molecular biology, and immunoassay.